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Pregnancy is a happy event and the start of a new life. How-
ever, owing to infections acquired or reactivated during
pregnancy, the dream of being pregnant may change to a
nightmare. Indeed, infections may impair fetal viability, may
cause long-term sequelae, or may lead to a variety of
adverse pregnancy outcomes, including miscarriage and pre-
term labour.
With this special issue on infections and pregnancy, our
aim is that infectious disease specialists and microbiologists
will have an overview on some major threats to the
materno-fetal unit.
Thus, in their review article [1], Lazzarotto et al. summa-
rize the current knowledge available on cytomegalovirus,
with a focus on congenital infection, prevention and diagno-
sis. In a nicely structured and educative article, Lazzarotto
et al. remind us of the major consequences for the fetal brain
of congenital infections, which may lead to hearing loss and/
or mental impairment. This article also outlines the main
preventive efforts that might be made, discussing vaccine
development, cytomegalovirus screening and behavioural
measures. Finally, Lazzarotto et al. summarize the diagnosis
of maternal infection, focusing especially on serology, which
remains the main diagnostic approach for this viral infection.
In the second article [2], Melin recapitulates current
knowledge on neonatal infection with Streptococcus agalactiae,
the major cause of neonatal sepsis. Her article clearly sum-
marizes the main issues concerning the prevention of this
infection: (i) gastrointestinal colonization with S. agalactiae is
common and generally asymptomatic, and screening has been
widely implemented, with a signiﬁcant impact; (ii) thanks to
the development of point-of-care tests, the impact of screen-
ing might increase; and (iii) intrapartum antibioprophylaxis to
reduce transmission to the neonate. Moreover, this article
also nicely reviews the pathogenesis and clinical presentation
of neonatal group B streptococcal infection, and presents
practical clues for the management of S. agalactiae neonatal
infection.
Because of space constraints, some important infectious
agents that threaten feto-maternal health have not been spe-
ciﬁcally covered in this special issue. Thus, as an example,
Toxoplasma gondii (Fig. 1), a strictly intracellular parasite that
causes congenital toxoplasmosis, may infect the fetus during
maternal primoinfection, with potentially major long-term
sequelae [3]. As congenital toxoplasmosis was recently
extensively reviewed [3,4], we have preferred to provide an
overview of two major health problems affecting pregnant
women: chorioamnionitis and miscarriage.
Thus, in the third article [5], Czikk et al. recapitulate all
that needs to be known about chorioamnionitis, including
pathogenesis, clinical presentation, aetiologies, diagnosis and
treatment. The mechanism of this infection, which is often
ascending following premature membrane rupture, remains
poorly understood as yet, and clearly merits greater atten-
tion, given the signiﬁcant associated morbidity.
FIG. 1. Toxoplasma gondii tachyzoites present in three distinct
vacuoles, as seen by immunoﬂuoresence. A secreted protein of
T. gondii (TgMIC6) that trafﬁc through the ER and Golgi is stained
with speciﬁc antibodies (in red) whereas another T. gondii protein
(TgMIC1), which is stored in secretory organelles called micro-
nemes, is stained in yellow. Confocal microscopy, 1000· magniﬁca-
tion. (This picture is a courtesy of Dominique Soldati-Favre, Geneva,
Switzerland).
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Finally, the last article summarizes current knowledge on
the role of intracellular bacteria in miscarriage, stillbirths and
preterm labour [6]. After an overview of Listeria monocytoge-
nes, which causes severe adverse pregnancy outcomes in
more than 30% of infected pregnant women, Baud et al.
recapitulate current knowledge on Coxiella burnetii infection,
which is a common cause of preterm delivery. Another
zoonotic intracellular bacterium, Brucella abortus, may also
cause adverse pregnancy outcomes (premature delivery or
miscarriage) and intrauterine infections. Finally, the roles of
different members of the order Chlamydiales are discussed in
this review article, including Chlamydia trachomatis, Chlamydia
abortus, Parachlamydia acanthamoebae and Waddlia chondro-
phila. The last of these, which is clearly associated with both
sporadic and recurrent miscarriage [7,8], should ideally be
screened for, at least after a ﬁrst episode of miscarriage,
as macrolide or doxycycline treatment might prevent an
additional episode of fetal loss.
In conclusion, with this special issue on infections and
pregnancy, we hope to increase awareness of physicians of
the many infectious threats that may impair the outcome of
pregnancy, and thus stimulate the implementation of preven-
tive measures and the development of more powerful
screening diagnostic approaches. Indeed, with modern micro-
biological approaches and excellent interactions between
obstetricians, paediatricians, microbiologists and infectious
disease specialists, it will be possible to further decrease the
number of future parents facing the nightmare of materno-
fetal infections and increase the proportion of parents who
will be able to live their dream with their healthy newborn.
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